AAAAAA

   
Results: 1-21 |
Results: 21
Decreased cyclin B1 expression contributes to G(2) delay in human brain tumor cells after treatment with camptothecin
Authors: Janss, AJ Maity, A Tang, CB Muschel, RJ McKenna, WG Sutton, L Phillips, PC
Citation: Aj. Janss et al., Decreased cyclin B1 expression contributes to G(2) delay in human brain tumor cells after treatment with camptothecin, NEURO-ONCOL, 3(1), 2001, pp. 11-21
Paradoxical effects of trichostatin A: inhibition of NF-Y associated acetyltransferase activity, phosphorylation of hGCN5 and down-regulation of cyclin A and B1 mRNA (vol 166, pg 55, 2001)
Authors: Nair, AR Boersma, LJ Schiltz, L Chaudhry, MA Muschel, RJ
Citation: Ar. Nair et al., Paradoxical effects of trichostatin A: inhibition of NF-Y associated acetyltransferase activity, phosphorylation of hGCN5 and down-regulation of cyclin A and B1 mRNA (vol 166, pg 55, 2001), CANCER LETT, 174(2), 2001, pp. 195-195
Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA
Authors: Nair, AR Boersma, LJ Schiltz, L Chaudry, A Muschel, RJ
Citation: Ar. Nair et al., Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA, CANCER LETT, 166(1), 2001, pp. 55-64
Untitled
Authors: Beland, FA Muschel, RJ Schwab, M Ito, N
Citation: Fa. Beland et al., Untitled, CANCER LETT, 162(1), 2001, pp. 1-1
Ras, metastasis, and matrix metalloproteinase 9
Authors: Bernhard, EJ Muschel, RJ
Citation: Ej. Bernhard et Rj. Muschel, Ras, metastasis, and matrix metalloproteinase 9, METH ENZYM, 333, 2001, pp. 96-104
Ras regulation of radioresistance in cell culture
Authors: Gupta, AK Bakanauskas, VJ McKenna, WG Bernhard, EJ Muschel, RJ
Citation: Ak. Gupta et al., Ras regulation of radioresistance in cell culture, METH ENZYM, 333, 2001, pp. 284-290
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras
Authors: Cohen-Jonathan, E Evans, SM Koch, CJ Muschel, RJ McKenna, WG Wu, JM Bernhard, EJ
Citation: E. Cohen-jonathan et al., The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras, CANCER RES, 61(5), 2001, pp. 2289-2293
The Ras radiation resistance pathway
Authors: Gupta, AK Bakanauskas, VJ Cerniglia, GJ Chen, Y Bernhard, EJ Muschel, RJ McKenna, WG
Citation: Ak. Gupta et al., The Ras radiation resistance pathway, CANCER RES, 61(10), 2001, pp. 4278-4282
Apoptosis: An early event in metastatic inefficiency
Authors: Wong, CW Lee, A Shientag, L Yu, J Dong, Y Kao, G Al-Mehdi, AB Bernhard, EJ Muschel, RJ
Citation: Cw. Wong et al., Apoptosis: An early event in metastatic inefficiency, CANCER RES, 61(1), 2001, pp. 333-338
Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis
Authors: Al-Mehdi, AB Tozawa, K Fisher, AB Shientag, L Lee, A Muschel, RJ
Citation: Ab. Al-mehdi et al., Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis, NAT MED, 6(1), 2000, pp. 100-102
DNA as an important target in radiation-induced apoptosis of MYC and MTC plus RAS transfected rat embryo fibroblasts
Authors: Ayene, IS Bernhard, EJ McKenna, WG Muschel, RJ Krisch, RE Koch, CJ
Citation: Is. Ayene et al., DNA as an important target in radiation-induced apoptosis of MYC and MTC plus RAS transfected rat embryo fibroblasts, INT J RAD B, 76(3), 2000, pp. 343-354
Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS
Authors: Cohen-Jonathan, E Muschel, RJ McKenna, WG Evans, SM Cerniglia, G Mick, R Kusewitt, D Sebti, SM Hamilton, AD Oliff, A Kohl, N Gibbs, JB Bernhard, EJ
Citation: E. Cohen-jonathan et al., Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS, RADIAT RES, 154(2), 2000, pp. 125-132
RAS-mediated radiation resistance is not linked to MAP kinase activation in two bladder carcinoma cell lines
Authors: Gupta, AK Bernhard, EJ Bakanauskas, VJ Wu, JM Muschel, RJ McKenna, WG
Citation: Ak. Gupta et al., RAS-mediated radiation resistance is not linked to MAP kinase activation in two bladder carcinoma cell lines, RADIAT RES, 154(1), 2000, pp. 64-72
BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression
Authors: MacLachlan, TK Somasundaram, K Sgagias, M Shifman, Y Muschel, RJ Cowan, KH El-Deiry, WS
Citation: Tk. Maclachlan et al., BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression, J BIOL CHEM, 275(4), 2000, pp. 2777-2785
Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines
Authors: Bernhard, EJ Stanbridge, EJ Gupta, S Gupta, AK Soto, D Bakanauskas, VJ Cerniglia, GJ Muschel, RJ McKenna, WG
Citation: Ej. Bernhard et al., Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines, CANCER RES, 60(23), 2000, pp. 6597-6600
Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression
Authors: Kupferman, ME Fini, ME Muller, WJ Weber, R Cheng, Y Muschel, RJ
Citation: Me. Kupferman et al., Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression, AM J PATH, 157(6), 2000, pp. 1777-1783
Radiosensitivity and the cell cycle
Authors: Bernhard, EJ McKenna, WG Muschel, RJ
Citation: Ej. Bernhard et al., Radiosensitivity and the cell cycle, CA J SCI AM, 5(4), 1999, pp. 194-204
Therapeutic resistance: characterization and inactivation by specific antiserum of a putative protein family produced by tumour cells
Authors: Zhou, S Li, W Hill, HZ Hill, GJ Kueppers, F McKenna, WG Muschel, RJ Wolansky, LJ Silva, HC
Citation: S. Zhou et al., Therapeutic resistance: characterization and inactivation by specific antiserum of a putative protein family produced by tumour cells, MELANOMA RE, 9(1), 1999, pp. 40-50
P34(Cdc2) kinase activity is excluded from the nucleus during the radiation-induced G(2) arrest in HeLa cells
Authors: Kao, GD McKenna, WG Muschel, RJ
Citation: Gd. Kao et al., P34(Cdc2) kinase activity is excluded from the nucleus during the radiation-induced G(2) arrest in HeLa cells, J BIOL CHEM, 274(49), 1999, pp. 34779-34784
'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
Authors: MacDougall, JR Bani, MR Lin, Y Muschel, RJ Kerbel, RS
Citation: Jr. Macdougall et al., 'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression, BR J CANC, 80(3-4), 1999, pp. 504-512
Radiosensitization and apoptosis
Authors: Muschel, RJ Soto, DE McKenna, WG Bernhard, EJ
Citation: Rj. Muschel et al., Radiosensitization and apoptosis, ONCOGENE, 17(25), 1998, pp. 3359-3363
Risultati: 1-21 |